The role of M&A in the pharmaceutical sector: a driver of scientific progress or an alternative to human capital?
Federici, Giorgio (A.A. 2024/2025) The role of M&A in the pharmaceutical sector: a driver of scientific progress or an alternative to human capital? Tesi di Laurea in Advanced corporate finance, Luiss Guido Carli, relatore Pierluigi Murro, pp. 60. [Master's Degree Thesis]
|
PDF (Full text)
Restricted to Registered users only Download (1MB) | Request a copy |
Abstract/Index
M&A trend. Definition and classification of M&A transactions. M&A in the pharmaceutical sector. Latest important deals. R&D as the main driver of scientific innovation. Historical analysis of R&D expenditure in big pharma. Big pharma: the top companies by revenue and research spending. Historical analysis of R&D and M&A investments by the top 9 pharmaceutical companies over the last 5 years. Historical analysis. Overall comparison between companies.
References
Bibliografia e sitografia: pp. 58-60.
| Thesis Type: | Master's Degree Thesis |
|---|---|
| Institution: | Luiss Guido Carli |
| Degree Program: | Master's Degree Programs > Master's Degree program in Corporate Finance, English language (LM-77) |
| Chair: | Advanced corporate finance |
| Thesis Supervisor: | Murro, Pierluigi |
| Thesis Co-Supervisor: | Santella, Rosella |
| Academic Year: | 2024/2025 |
| Session: | Autumn |
| Deposited by: | Alessandro Perfetti |
| Date Deposited: | 03 Mar 2026 07:31 |
| Last Modified: | 03 Mar 2026 07:31 |
| URI: | https://tesi.luiss.it/id/eprint/45019 |
Downloads
Downloads per month over past year
Repository Staff Only
![]() |
View Item |



